Skip to content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

  • Ann De Vos1,
  • Maria Bjerke2,
  • Raf Brouns3,
  • Naomi De Roeck2,
  • Dirk Jacobs1,
  • Lien Van den Abbeele1,
  • Kaat Guldolf2, 4,
  • Henrik Zetterberg5, 6, 7,
  • Kaj Blennow5, 6,
  • Sebastiaan Engelborghs2, 4 and
  • Eugeen Vanmechelen1Email authorView ORCID ID profile
BMC NeurologyBMC series – open, inclusive and trusted201717:170

Received: 23 February 2017

Accepted: 21 August 2017

Published: 30 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting

Original Submission
23 Feb 2017 Submitted Original manuscript
6 Apr 2017 Reviewed Reviewer Report - Mie Kurata
27 Jun 2017 Reviewed Reviewer Report - Majaz Moonis
14 Jul 2017 Author responded Author comments - Ann De Vos
Resubmission - Version 2
14 Jul 2017 Submitted Manuscript version 2
21 Aug 2017 Editorially accepted
30 Aug 2017 Article published 10.1186/s12883-017-0945-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting

You can find further information about the peer review system here.

Authors’ Affiliations

ADx NeuroSciences NV, Ghent, Belgium
Reference Center for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium
Department of Neurology, Hospital ZorSaam, Terneuzen, The Netherlands
Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK